Gilead Sciences appoints Dietmar Berger as Chief Medical Officer
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate
Based on data, 1.75 mg/kg dose established as recommended dose for Phase 3 trial of this investigational antibody-drug conjugate
The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily single-pill regimen
Venus Remedies secures marketing authorization in Philippines
Sitagliptin and Metformin Hydrochloride Tablets, 50 mg/500 mg and 50 mg/1000 mg are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
The product will be marketed by Dr. Reddy's
Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the US
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Subscribe To Our Newsletter & Stay Updated